2026-02-10T09:44:24-06:00 2025-06-30 650715836 ZOMMA GROUP LLP 355 ALHAMBRA CIRCLE SUITE 1100 CORAL GABLES FL 33134 990 2024-07-01 201048322 COPD FOUNDATION INC COPD 8667312673 3300 PONCE DE LEON BLVD MIAMI FL 33134 KALEO CURTIS CFO 8667312673 2026-02-04 1 1 MARGARITA G LISKER CPA P00957338 3054448288 2026-02-04 2024 2025-03-06 01:10:19Z KALEO CURTIS 3300 PONCE DE LEON BLVD MIAMI FL 33134 15905580 0 X WWW.COPDFOUNDATION.ORG X 2004 FL SEE SCHEDULE O.THE COPD FOUNDATION IS A PATIENT-CENTERED ORGANIZATION COMMITTED TO PREVENTING COPD, BRONCHIECTASIS, AND NONTUBERCULOUS MYCOBACTERIAL (NTM) LUNG DISEASE, AND TO SEEKING CURES WHILE IMPROVING LIVES AND ADVOCATING FOR ALL AFFECTED. 18 18 46 337 0 0 10426406 13595105 158446 189245 389622 544334 0 52660 10974474 14381344 21000 0 0 0 4126285 5063571 0 0 999258 6708103 7542483 10855388 12606054 119086 1775290 10152011 12515154 4715573 5176999 5436438 7338155 X THE COPD FOUNDATION WAS ESTABLISHED TO IMPROVE THE LIVES OF PEOPLE WITH COPD, BRONCHIECTASIS, AND NONTUBERCULOUS MYCOBACTERIAL (NTM) LUNG DISEASE THROUGH INITIATIVES THAT EXPAND SERVICES AND SPEED INNOVATIONS WHICH WILL MAKE TREATMENT MORE EFFECTIVE AND AFFORDABLE.WE DO THIS THROUGH SCIENTIFIC RESEARCH, EDUCATION, ADVOCACY, AND AWARENESS WITH THE GOAL OF DISEASE PREVENTION, SLOWED PROGRESSION, AND ULTIMATELY A CURE. 0 0 3282165 RESEARCH & MEDICALTHE COPD FOUNDATION RESEARCH TEAM ENGAGES WITH MULTIPLE INDIVIDUALS AND ORGANIZATIONS TO SUPPORT RESEARCH STUDIES AND CLINICAL TRIALS. THESE STUDIES FOCUS ON A WIDE RANGE OF TOPICS THAT ALIGN WITH THE FOUNDATION MISSION. THESE INCLUDE PATIENT SYMPTOM TREATMENT, VIRTUAL COPD MANAGEMENT TOOLS, PATIENT FEEDBACK ON SCREENING TOOLS, AND DEVELOPMENT OF NEW THERAPIES AND MEDICAL DEVICES TO ADDRESS UNMET NEEDS. THE COPD FOUNDATION RESEARCH TEAM ALSO PARTICIPATED IN SEVERAL ACTIVITIES THAT ARE TARGETING PEOPLE WITH EARLY COPD WITH THE AIM TO DEVELOP APPROACHES THAT CAN BE USED TO SLOW DISEASE PROGRESSION THESE INCLUDE AN AMERICAN THORACIC SOCIETY EARLY DISEASE WORKING GROUP, CO-CHAIRED BY THE COPD FOUNDATION AND DISCUSSIONS RELATED TO THE DESIGN AND CONDUCT OF CLINICAL TRIALS IN PATIENTS WITH EARLY DISEASE.THE COPD FOUNDATION IS CONTINUING THE WORK OF THE PATIENT INSPIRED VALIDATION OF OUTCOME TOOLS (PIVOT) PROJECT. PIVOT WAS ESTABLISHED TO BE A DRIVING FORCE FOR INTEGRATING THE PATIENT AND THE PATIENT VOICE INTO CLINICAL OUTCOME MEASUREMENT VALIDATION AND SELECTION FOR USE IN CHRONIC LUNG DISEASE RESEARCH AND CLINICAL TRIALS. THE PIVOT PROJECT HAS PRODUCED TWO MANUSCRIPTS, ONE TO DESCRIBE THE OBJECTIVES OF PIVOT AND A SECOND REPORTING THE FIRST RESULTS OF ANALYSIS OF WHAT MATTERS MOST TO PATIENTS WITH COPD. OVER THE NEXT YEAR THE PIVOT TEAM WILL CONDUCT A SURVEY OF COPD PATIENTS TO BETTER UNDERSTAND THE HETEROGENEITY IN HOW COPD PATIENTS EXPERIENCE THEIR DISEASE IN THEIR DAILY LIVES AND WHAT IS MOST IMPORTANT TO THEM IN TERMS OF UNMET NEEDS. IN THE COMING YEAR, THE PIVOT TEAM WILL ALSO BEGIN SIMILAR WORK IN NON-CYSTIC FIBROSIS BRONCHIECTASIS.THE COPD FOUNDATION CONTINUES TO PRIORITIZE THE DEVELOPMENT OF ITS PATIENT POWERED RESEARCH NETWORK OR PPRN, A NETWORK IN WHICH PATIENTS ARE RECRUITED TO SHARE THEIR HEALTH INFORMATION AND DISEASE IMPACT. PATIENT PROVIDED HEALTH INFORMATION IS STORED IN A SECURE DATABASE AND IS USED TO SUPPORT PROJECTS WHERE PATIENT INPUT IS NEEDED. THE PPRN IS CURRENTLY BEING USED TO SUPPORT MULTIPLE ONGOING RESEARCH STUDIES AND CLINICAL TRIAL ACTIVITIES. 3658163 BRONCHIECTASIS & NTM ASSOCIATIONTHE COPD FOUNDATION WAS APPROVED TO DO BUSINESS AS THE BRONCHIECTASIS AND NTM ASSOCIATION. WITH THIS APPROVAL, WE EMBARKED ON A REBRANDING EFFORT, ENSURING OUR COMMITMENT AND DEDICATION TO THIS PATIENT COMMUNITY.WE HAD ANOTHER SUCCESSFUL WORLD BRONCHIECTASIS DAY CAMPAIGN, REACHING OVER 2 MILLION PEOPLE. THE CAMPAIGN ALLOWED US TO BRING TOGETHER NEARLY 20 PATIENT ADVOCACY ORGANIZATIONS AND PROFESSIONAL SOCIETIES TO COLLABORATE IN SPREADING AWARENESS AND EDUCATION ON BRONCHIECTASIS.THE GOAL OF THE BRONCHIECTASIS AND NTM RESEARCH REGISTRY IS TO SUPPORT COLLABORATIVE RESEARCH AND ASSIST IN THE PLANNING OF MULTI-CENTER CLINICAL TRIALS FOR THE TREATMENT OF NON-CF BRONCHIECTASIS AND/OR NTM LUNG DISEASE. OVER THE COURSE OF THE YEAR, THE REGISTRY CONTINUED ENROLLING AND COLLECTING LONGITUDINAL DATA ON PARTICIPANTS, REACHING OVER 8,000 PARTICIPANTS AND UP TO 16 YEARS OF DATA ON SOME PARTICIPANTS. SEVERAL REGISTRY ABSTRACTS WERE PRESENTED AT INTERNATIONAL CONFERENCES AND MANUSCRIPTS WERE PUBLISHED AS A RESULT OF THE REGISTRY DATA COLLECTION. IN ADDITION, THE REGISTRY WAS UTILIZED TO FACILITATE RECRUITMENT INTO MAJOR CLINICAL TRIALS IN THIS SPACE.THE BRONCHIECTASIS AND NTM CARE CENTER NETWORK'S MISSION IS TO REDUCE THE TIME TO DIAGNOSIS AND SUPPORT HIGH QUALITY CARE FOR THIS PATIENT POPULATION. THE CARE CENTER NETWORK SUCCESSFULLY ONBOARDED 33 CENTERS AND CONTINUED PLANNING FOR THE NEXT REQUEST FOR APPLICATIONS. 714987 COMMUNITYTHE COPD360 COMMUNITY ENGAGEMENT COMMITTEE (COPD360CENCO), A DIVERSE PATIENTS AND CAREGIVERS COMMITTEE, CONTINUED TO MEET MONTHLY TO PROVIDE THE VOICE OF PATIENTS AND CAREGIVERS TO ALL THE COPD FOUNDATION'S EFFORTS, AND TO SUPPORT ITS INTERACTIONS WITH OTHER HEALTH CARE AND ADVOCACY ORGANIZATIONS. PATIENT AND CAREGIVER INVOLVEMENT IN GOVERNANCE AND EDUCATION IS THE MODEL ON WHICH THE COPD FOUNDATION WAS ESTABLISHED. WITH THAT CENTRAL GOAL, THE COPD FOUNDATION HAS BUILT TRUST WITHIN ITS MEMBERSHIP AND RELATED STAKEHOLDER GROUPS.MEMBERSHIP IN THE COPD FOUNDATION CAPTAINS PROGRAM GREW BY 13%. CAPTAINS SPREAD COPD AWARENESS IN THEIR STATE AND LOCAL AREAS, MENTOR FELLOW COPD COMMUNITY MEMBERS, AND PARTICIPATE IN GRASSROOTS ADVOCACY AND COMMUNITY BUILDING ACTIVITIES FOCUSED ON HEALTH POLICY ISSUES THAT ARE IMPORTANT TO THOSE WHO HAVE COPD AND OTHER CHRONIC LUNG DISEASES. THE COPD FOUNDATION CONTINUES TO SUPPORT PATIENT WELLBEING BY PROVIDING FREE MONTHLY SUPPORT GROUPS FOR PATIENTS AND CAREGIVERS. SUPPORT GROUPS ARE AVAILABLE FOR BOTH PATIENTS WITH COPD AND PATIENTS WITH BRONCHIECTASIS AND (NONTUBERCULOUS MYCOBACTERIAL) NTM LUNG DISEASE. HUNDREDS OF PATIENTS ATTEND THESE MEETINGS EACH MONTH TO DISCUSS THEIR EXPERIENCES AND LEARN ABOUT TOPICS SUCH AS STAYING HEALTHY DURING THE HOLIDAYS AND TALKING TO THEIR HEALTH CARE PROVIDERS ABOUT THEIR SPECIFIC ISSUES AND SYMPTOMS. 666485 PUBLIC & PROFESSIONAL EDUCATIONTHE COPD FOUNDATION CONTINUES TO ENSURE HIGH-QUALITY EVIDENCE-BASED EDUCATIONAL MATERIALS ARE AVAILABLE FOR INTERNAL AND EXTERNAL STAKEHOLDERS. THE COPD FOUNDATION PODCAST RELEASED 12 EPISODES IN 2025, PROVIDING INSIGHTS FROM KEY OPINION LEADERS (KOLS) ON TOPICS RELATED TO COPD CARE. TWO NEW PATIENT-FACING 101 DECKS, ONE FOCUSING ON INTRODUCING COPD, AND THE OTHER DISCUSSING GENETIC COPD. TWO NEW LANDING PAGES WERE ALSO DEVELOPED - ONE ON SEVERE COPD THAT PROVIDES GUIDANCE ON MANAGEMENT, AND THE OTHER ON GENETIC COPD, WHICH ENCOURAGES TESTING FOR THE GENETIC CONDITION. TO SUPPORT PEOPLE LIVING WITH COPD IN A GROUP SETTING, RESOURCES TO SUPPORT GROUPS IN PROVIDING EFFECTIVE PEER SUPPORT AND EDUCATION WERE CREATED AND PROVIDED TO SEVERAL COMMUNITIES IN RURAL AREAS ACROSS THE COUNTRY. TO HELP IMPROVE THE DIAGNOSIS OF COPD IN RURAL COMMUNITIES, COPD SCREENING AND COPD EDUCATION WERE CONDUCTED AT NUMEROUS EVENTS IN FOUR STATES IN THE APPALACHIAN REGION. A MEDIA AND DIRECT MAIL CAMPAIGN PROMOTED COPD AWARENESS, AND THE USE OF PULMONARY REHABILITATION IN THESE AREAS, AND THREE PULMONARY REHABILITATION PROGRAMS IN THESE REGIONS WERE PROVIDED WITH FREE EDUCATIONAL MATERIALS.THE COPD FOUNDATION ALSO DEMONSTRATES A COMMITMENT TO PROVIDING HIGH-QUALITY EDUCATION FOR HEALTH CARE PROVIDERS WHO CARE FOR PEOPLE WITH CHRONIC LUNG DISEASE. SEVERAL CONTINUING MEDICAL EDUCATION PROGRAMS OR ACCREDITED PROGRAMS WERE PROVIDED FOR PROFESSIONAL DEVELOPMENT. THE LUNG HEALTH COLLABORATIVE WAS DEVELOPED AS A COMMUNITY OF PROVIDERS COMMITTED TO PROVIDING EFFECTIVE CARE FOR PEOPLE WITH CHRONIC LUNG DISEASE. THIS GROUP HAS AN ONLINE FORUM FOR COLLABORATION AND A DEDICATED NEWSLETTER. THE INAUGURAL LUNG HEALTH COLLABORATIVE VIRTUAL ASSEMBLY PROVIDED A FULL DAY OF EDUCATIONAL SESSIONS FOR HEALTH PROFESSIONALS. THESE SESSIONS WERE HELD BY KOLS AND DISCUSSED NOVEL COMPONENTS OF COPD CARE. 664875 ADVOCACY & PUBLIC POLICYTHE COPD FOUNDATION COMMUNITY WORKS WITH LOCAL, STATE, AND FEDERAL POLICY MAKERS TO INCREASE RESEARCH FUNDING, IMPROVE CARE DELIVERY, PROTECT ACCESS TO TREATMENTS, AND CREATE POLICY THAT IMPROVES THE LIVES OF THOSE WITH COPD, BRONCHIECTASIS AND NONTUBERCULOUS MYCOBACTERIAL (NTM) LUNG DISEASE. THE COPD FOUNDATION CENTERED ITS FY25 POLICY EFFORTS ON THE FOLLOWING PRIORITIES:1. INCREASING RESEARCH FUNDING2. ADVANCING PATIENT-CENTERED TREATMENT APPROVALS3. IMPROVING ACCESS TO OXYGEN THERAPY4. EXPANDING PULMONARY REHABILITATION5. REDUCING TOBACCO AND NICOTINE USEPROGRESS HAS BEEN MADE ON ALL POLICY PRIORITIES AS A DIRECT RESULT OF COPD FOUNDATION ADVOCACY EFFORTS. THIS INCLUDES THE PROGRESSION OF PULMONARY REHABILITATION AND SUPPLEMENTAL OXYGEN LEGISLATION THROUGH CONGRESS AND THE SUBMISSION OF OVER 100 BUDGET REQUESTS TO LEGISLATIVE OFFICES FOR THE FY26 APPROPRIATIONS CYCLE. OVER 75 ADVOCATES JOINED THE COPD FOUNDATION IN WASHINGTON, D.C. TO ADVOCATE FOR CRITICAL LUNG HEALTH POLICIES DURING THE IMPACT LUNG HEALTH 2025 LEGISLATIVE ADVOCACY CAMPAIGN, REPRESENTING 52 SENATE DISTRICTS, 53 HOUSE DISTRICTS, AND 26 STATES. 1331360 8986675 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 92 0 1 46 1 0 0 0 0 0 0 0 0 0 0 X 18 18 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 FL X X THE ORGANIZATION 8667312673 3300 PONCE DE LEON BLVD MIAMI FL 33134 JAMES D CRAPO MD BOARD CHAIR 10.00 X 0 0 0 VALERIE CHANG ESQ VICE CHAIR 2.00 X X 0 0 0 RICHARD CASABURI PHD MD DIRECTOR 2.00 X 0 0 0 STEW COGAN ESQ DIRECTOR 2.00 X 0 0 0 PHYLISS DILORENZO DIRECTOR 2.00 X 0 0 0 MARK DRANSFIELD MD DIRECTOR 2.00 X 0 0 0 LEONARD FROMER MD DIRECTOR 2.00 X 0 0 0 MEILAN HAN MD DIRECTOR 2.00 X 0 0 0 JIM HARRIS DIRECTOR 2.00 X 0 0 0 JERRY KRISHNAN PHD DIRECTOR 2.00 X 0 0 0 DAVID MANNINO PHD DIRECTOR 2.00 X 0 0 0 WILLIAM PILKINGTON DPA MPA MA DIRECTOR 2.00 X 0 0 0 CINDY PRAEGER EMP DIRECTOR 2.00 X 0 0 0 MIKE ROGERS DIRECTOR 2.00 X 0 0 0 JEAN ROMMES PHD DIRECTOR 2.00 X 0 0 0 RISA STACK PHD DIRECTOR 2.00 X 0 0 0 BYRON M THOMASHOW MD DIRECTOR 2.00 X 0 0 0 JOHN TORRENCE DIRECTOR 2.00 X 0 0 0 VINCENT MALANGA EVP, CHIEF INFORMATION OFFICER 40.00 X 220776 0 19380 ELISHA MALANGA CHIEF CORPORATE RELATIONS OFFICER 40.00 X 165743 0 39531 KALEO CURTIS CHIEF FINANCIAL OFFICER 40.00 X 168644 0 31524 JEAN WRIGHT MD MBA CHIEF EXECUTIVE OFFICER 40.00 X 295381 0 29418 SASHA LAVIN SR DIRECTOR OF FINANCE 40.00 X 141238 0 16362 CRYSTAL ROTHHAAR VP, MARKETING & COMMUNICATIONS 40.00 X 150024 0 18273 DELIA PRIETO OLIVER VP, BRONCHIECTASIS OPERATIONS 40.00 X 123543 0 17328 PETER AMARI VP, INFORMATION TECHNOLOGY & DESIGN 40.00 X 119329 0 0 1384678 0 171816 8 0 1 0 BEM CONSULTING LLC 45 DIAMOND ROCK ROAD PHOENIXVILLE PA 19460 CONTRACTOR 203750 FAEGRE DRINKER BIDDLE & REATH LLP 300 NORTH MERIDIAN STREET INDIANAPOLIS IN 46204 CONTRACTOR 148525 DMANNINO CONSULTING LLC 146 CASSEEKEE TRAIL MELBOURNE BEACH FL 32951 CONTRACTOR 110000 3 17644 13577461 13595105 PUBLICATION INCOME 513190 189245 189245 189245 270564 270564 1722815 1449045 273770 273770 273770 122851 75191 47660 47660 MISCELLANEOUS 900099 5000 5000 5000 14381344 468015 0 318224 X 939333 535157 378706 25470 2972638 1668904 951216 352518 859068 486834 266737 105497 292532 169829 93317 29386 31236 31236 18000 18000 120000 120000 5585939 4918394 418257 249288 73859 49204 5626 19029 135564 78594 45156 11814 6844 6844 331698 238632 71215 21851 274875 227035 9834 38006 6075 6075 68075 7625 59156 1294 LICENSES AND FEES 558530 326147 169452 62931 DUES & SUBSCRIPTIONS 151645 50919 51910 48816 PRINTING AND PUBLICATIO 78089 57261 1356 19472 MEALS 60753 41997 16062 2694 41301 10143 19966 11192 12606054 8986675 2620121 999258 2501373 4747066 882395 902508 1992319 1816196 870516 562033 47577 39438 14215 8139 3299538 3887768 591655 591444 10152011 12515154 815420 1026187 3900153 4150812 4715573 5176999 X 2008668 2710580 3427770 4627575 5436438 7338155 10152011 12515154 1775290 126427 0 X X 0 1 X 1 0 X 8102975 7630964 7495120 10426406 13600105 47255570 8102975 7630964 7495120 10426406 13600105 47255570 47255570 104551 142019 270564 517134 47772704 0.98920 0.99110 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 1 179400 0 1 120000 299400 0 PART II-B, LINE 1: THE ORGANIZATION ENTERED INTO AN AGREEMENT WITH FAEGRE DRINKER CONSULTING TO PROVIDE DIRECT FEDERAL LOBBYING SERVICES, DEVELOP REGULATORY INITIATIVES, SUPPORT AGENCY PRIORITIES AND ADVISE ON ADVOCACY STRATEGIES RELATED TO THE ORGANIZATIONS' S EXEMPT PURPOSE. 47577 39438 8139 8139 X 16820256 126427 2317485 2443912 14376344 5000 5000 14381344 14918539 2317485 2317485 12601054 5000 5000 12606054 PART X, LINE 2: THE ORGANIZATION IS ORGANIZED AS A NOT-FOR-PROFIT ENTITY AND IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C) (3) OF THE INTERNAL REVENUE CODE. UNRELATED BUSINESS INCOME, OF WHICH THE ORGANIZATION HAD NONE FOR THE YEARS ENDED JUNE 30, 2024 AND 2023, WOULD BE SUBJECT TO FEDERAL INCOME TAXES. THE ORGANIZATION'S INFORMATION RETURNS FILED WITH THE INTERNAL REVENUE SERVICE HAVE NOT BEEN EXAMINED IN THE PAST. THE ORGANIZATION IS NOT AWARE OF ANY UNCERTAINTIES THAT COULD JEOPARDIZE ITS NOT-FOR-PROFIT STATUS. THEREFORE, NO PROVISION OR LIABILITY FOR INCOME TAXES IS DEEMED NECESSARY. THE ORGANIZATION FOLLOWS THE PROVISIONS OF UNCERTAIN TAX PROVISIONS ADDRESSED BY FAS ASC 740-10 ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE ORGANIZATION HAS NO UNCERTAIN TAX POSITIONS AT JUNE 30, 2024 AND 2023, FOR WHICH THE ULTIMATE DEDUCTIBILITY IS HIGHLY CERTAIN BUT FOR WHICH THERE ARE UNCERTAINTY ABOUT THE TIMING OF SUCH DEDUCTIBILITY. THE ORGANIZATION RECOGNIZES INTEREST ACCRUED RELATED TO UNRECOGNIZED TAX BENEFITS IN INTEREST EXPENSE AND PENALTIES IN OPERATING EXPENSE. THE ORGANIZATION HAS DETERMINED THAT NO AMOUNT REQUIRED TO BE ACCRUED FOR TAXES OR RELATED PENALTIES AND INTEREST FOR ANY TAX POSITION TAKEN THROUGH JUNE 30, 2024 AND 2023. PART XI, LINE 4B - OTHER ADJUSTMENTS: AWARDS AND GRANTS 5,000. PART XII, LINE 4B - OTHER ADJUSTMENTS: AWARDS AND GRANTS 5,000. 122851 122851 63000 12191 122851 122851 63000 12191 75191 47660 X X 0 0 0 0 0 0 0 0 0 JEAN WRIGHT MD MBA CHIEF EXECUTIVE OFFICER 295381 0 0 0 0 0 0 0 29418 0 324799 0 0 0 VINCENT MALANGA EVP, CHIEF INFORMATION OFFICER 220776 0 0 0 0 0 0 0 19380 0 240156 0 0 0 ELISHA MALANGA CHIEF CORPORATE RELATIONS OFFICER 165743 0 0 0 0 0 0 0 39531 0 205274 0 0 0 KALEO CURTIS CHIEF FINANCIAL OFFICER 168644 0 0 0 0 0 0 0 31524 0 200168 0 0 0 CRYSTAL ROTHHAAR VP, MARKETING & COMMUNICATIONS 150024 0 0 0 0 0 0 0 18273 0 168297 0 0 0 SASHA LAVIN SR DIRECTOR OF FINANCE 141238 0 0 0 0 0 0 0 16362 0 157600 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 ELISHA MALANGA (CORPORATE RELATIONS OFFICER) AND VINCENT MALANGA (EVP, CHIEF INFORMATION OFFICER) ARE MARRIED. FORM 990, PART VI, SECTION B, LINE 11B AFTER REVIEW BY THE CFO, THE DRAFT FORM 990 IS CIRCULATED TO MEMBERS OF MANAGEMENT FOR REVIEW AND COMMENT. THE FORM 990 IS THEN PROVIDED TO THE FOUNDATION'S BOARD OF DIRECTORS FOR REVIEW PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C AT EACH BOARD MEETING THE CONFLICT OF INTEREST POLICY IS READ BEFORE THE CONDUCT OF ANY OTHER ITEM. WRITTEN CONFLICT OF INTEREST STATEMENTS ARE OBTAINED FROM ALL OFFICERS, BOARD MEMBERS, COMMITTEE MEMBERS, STAFF AND CONTRACTED PERSONNEL ANNUALLY. FAILURE TO FILE THE STATEMENT MAY RESULT IN THE PERSON BEING REMOVED FROM THE BOARD, COMMITTEE(S), EMPLOYMENT, AND/OR CONTRACTUAL RELATIONSHIP WITH THE FOUNDATION. FORM 990, PART VI, SECTION B, LINE 15 SALARIES FOR COPD FOUNDATION MANAGEMENT ARE DETERMINED BY ANNUAL SURVEYS OF COMPARABLE NOT-FOR-PROFIT ORANIZATIONS. FORM 990, PART VI, SECTION C, LINE 19 THE WEBSITE WWW.COPDFOUNDATION.ORG INCLUDES THE POSTING OF FINANCIAL STATEMENTS, FORM 990, ANNUAL REPORT, CONFLICT OF INTEREST POLICY AND WHISTLEBLOWER POLICY. FORM 990, PART IX, LINE 11G CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 4,918,394. MANAGEMENT AND GENERAL EXPENSES 418,257. FUNDRAISING EXPENSES 249,288. TOTAL EXPENSES 5,585,939. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.